Seaview Trust 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:20 pm Sale |
2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Seaview Trust | 7,041,120 4.940% |
-299,747 (-4.08%) |
Filing |
| 2021-02-12 1:00 pm Sale |
2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Seaview Trust | 7,340,867 5.200% |
-1,251,741 (-14.57%) |
Filing |